The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid prescription fills by one third, according to goals released Friday for its National Drug Control Strategy. Among other goals for 2022, the office aims to have 20 percent of specialty treatment facilities providing medication-assisted treatment, 10 percent of practitioners certified to prescribe and dispense buprenorphine for opioid use disorder, and 72 percent of federal prescribers complete continuing education on opioid best practices and clinical guidelines. It also aims to increase to 30 the number of states integrating electronic health records with their prescription drug monitoring programs. The office released its National Drug Control Strategy in February to guide federal efforts to reduce the availability and use of illicit drugs and barriers to substance use disorder treatment.

Related News Articles

Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
Laws that allow pharmacists to dispense the opioid antidote naloxone without a physician’s prescription are associated with a sharp reduction in fatal opioid-…
Perspective
Investing in our country’s health infrastructure is the right move to make.
Headline
The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, of which the AHA is a sponsor, held a two-day meeting this week…
Headline
The Food and Drug Administration yesterday launched a campaign to help Americans understand the importance of removing unused prescription opioids from their…